This new report from LeadingMarketResearch.com presents a seven-country strategic analysis of major business opportunities emerging in the GI disease testing market during the next five years. The report reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales by country; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

This comprehensive seven-country report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding GI testing market, in evaluating emerging opportunities and developing effective business strategies.

Worldwide Market Overview

- Estimated universe of laboratories performing GI testing by country.
- Test volume and sales projections for major GI assays by country.
-  Test volume by method (molecular, serology/immunodiagnostics, culture/microscopy).

Opportunities and Strategic Recommendations

- Emerging opportunities for new instrumentation, reagents kits, IT and other products with significant market appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

GI Tests Analyzed in the Report

Calprotectin
Campylobacter
Carbapenemase
Clostridium
Cryptosporidium
E. Coli
Giardia
Helicobacter Pylori
Norovirus
Rotavirus
Salmonella
Vancomycin-Resistant Enterococci

Geographic Coverage

France, Germany, Italy, Japan, Spain, UK, USA

Current and Emerging Products

- In-depth examination of major GI diseases, including their etiology, current diagnostic tests, vaccines, drugs and market needs.

Technology Review

- Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for GI testing.

- Global listings of companies developing or marketing GI diagnostic products by individual test.

Competitive Assessments

- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.